- GlobeNewswire•12 days ago
TORONTO, Feb. 10, 2017-- Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release ...
- Investopedia•19 days ago
The FDA accepted Intellipharmaceutics's new drug application for its opioid painkiller Rexista.
- GlobeNewswire•20 days agoIntellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista™ (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
TORONTO, Feb. 02, 2017-- Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release ...
IPCI : Summary for Intellipharmaceutics Internatio - Yahoo Finance
IntelliPharmaCeutics International Inc. (IPCI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.35 x 1200|
|Ask||2.49 x 500|
|Day's Range||2.35 - 2.49|
|52 Week Range||1.41 - 3.35|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.32|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|